X-imaging provides full-process automation solutions for customers in life sciences, medical diagnostics, and inspection and testing. The company completed a B round financing described as exceeding ¥100 million and plans to increase product R&D investment and expand market layout. X-imaging aims to use AI to advance scientific research and has assembled a team of application scientists, AI experts, automation specialists, and engineers. It recently launched the "智灵者" intelligent robot series and an intelligent liquid technology platform. These products are intended to improve scientists' research efficiency and shorten the cycle for producing research outcomes. The company will use the new funding to deepen its presence in its target sectors and accelerate product development. Shanghai Huixiang Information Technology develops imaging-centered laboratory automation systems that combine artificial intelligence, biochemical methods and high-throughput experimentation to deliver end-to-end solutions from molecular to cell-level testing. The company focuses on integrating instruments and intelligent data analysis to address high sample complexity, batch variability, testing accuracy and report traceability. Its systems are applied in food safety, life sciences, environmental protection and biopharmaceutical safety control to detect harmful chemicals, bacteria and viruses. Huixiang reports having served nearly 100 clients and delivered hundreds of automated inspection and testing systems. The company emphasizes full-process automation, its self-developed intelligent network system that connects with over 90% of market instruments, and ongoing R&D. Management says it will continue to expand offerings in AI detection robots, AI instruments, AI diagnostic systems and reagents/consumables, with particular attention to virus and microbiology testing amid the COVID environment.

Total raised

$14M

Funding rounds

2

Latest round

Series B

Latest activity

Dec 2023